The 2024 National Health Care Fraud Action: Intended Loss, Paid Claims and Seized Assets

Whistleblower Justice Network

The 2024 national Medicare fraud takedown brought charges against 193 defendants across 32 federal districts in a coordinated action announced on June 27, 2024. The charges described arrangements someone inside healthcare could recognize: marketers obtaining genetic-testing orders, sales representatives choosing wound products, and claims following decisions made before the bill was submitted.

The action covered Medicare and Medicaid fraud as well as schemes involving private insurers. The Justice Department’s Fraud Section led the effort with U.S. Attorney’s Offices and state partners. Its court-document index brings together separate prosecutions, each with its own defendants, claims and evidence.

The Justice Department’s 2024 annual report also describes criminal charges involving telemedicine and laboratory fraud, addiction-treatment schemes, and the distribution of adulterated and misbranded HIV medication. The action included charges of unlawfully distributing Adderall and other stimulants through a digital technology company. The laboratory and wound-care cases show how paid referrals could reach both the physician’s order and the treatment itself.

2024 National Healthcare Fraud Action Intended Versus Actual Loss

The government’s June announcement paired approximately $2.75 billion in alleged intended loss with $1.6 billion labeled actual loss. Those are losses across the action’s payers, not a Medicare recovery.

A billing employee may know what went onto the claim. Someone in finance may know what arrived in the account. Connecting those views gives a loss figure meaning.

Is Stopped or Seized Money the Same as Money Returned to Medicare?

No. Stopping a payment or seizing property does not put money back in Medicare’s account. The announcement also reported more than $231 million seized and action by the Centers for Medicare & Medicaid Services against 127 providers during the preceding six months. The Fraud Section’s annual account describes cash, luxury vehicles, gold and other assets among the property seized. It describes the administrative actions as revocations and billing suspensions.

What Is the Medicare Fraud Strike Force?

The Medicare fraud strike-force network brings prosecutors and investigators together to pursue healthcare fraud. The Justice Department’s annual report describes a national effort involving its Health Care Fraud Unit, U.S. Attorney’s Offices, state attorneys general, Medicaid Fraud Control Units and law-enforcement partners.

CMS and its contractors also work on the payment side. Medicare Administrative Contractors process claims. Unified Program Integrity Contractors investigate leads through claims analysis, interviews, site visits and medical review, and refer suspected fraud to law enforcement.

The pressure to pay promptly has long shaped that work. In its 2011 report, Medicare Program Integrity: Activities to Protect Medicare from Payment Errors, Fraud, and Abuse, the Congressional Research Service described how quick reimbursement requirements created a pay-and-chase approach. It also described contractors developing suspected fraud cases for referral to the Department of Health and Human Services’ Office of Inspector General and the Justice Department.

The national action shows those different jobs meeting: claims review, investigation, prosecution and controls over further billing. For an insider, the connection may begin with a much smaller question, such as why a marketer is involved in getting a physician to sign a test order.

The Laboratory Pattern Behind the Billing Spike

The annual report describes Axis Professional Laboratories, LLC, a Texas laboratory, as a billing outlier for cardiac genetic testing. Investigators examined diagnosis codes to understand the tests behind generic billing codes. Continued tracking led them to a second laboratory, Kingdom Health Laboratory, and to an unusual feature of the referrals.

Earlier cancer-testing cases had concentrated orders among a small number of providers. Here, many different medical providers referred the tests. The report says that pattern pointed investigators toward marketers obtaining orders from beneficiaries’ own primary care physicians.

According to the report’s account of the June criminal indictment, the laboratories’ owner allegedly paid marketers kickbacks for beneficiaries’ DNA samples, identifying information, Medicare numbers and signed doctors’ orders. The marketers allegedly used other companies to solicit beneficiaries and pressure their physicians to approve tests for patients presented as already qualified for testing. The report calls this a doctor-chase model.

The allegation puts a familiar signature in a different light. The physician’s name was on the order, but prosecutors alleged that paid marketers drove the process that produced it. Someone in a practice could recognize those requests. Someone in a laboratory could recognize the marketing payments attached to the incoming specimens.

Wound Grafts Chosen Before an Independent Assessment

The Arizona wound-graft charges described another route from marketing to a Medicare claim. In its account of the criminal charges, the annual report says the defendants allegedly paid medically untrained sales representatives to identify patients, assess wounds, and order or recommend grafts. A separate company contracted with nurse practitioners to apply them.

The charges alleged that grafts were applied regardless of medical necessity and without an independent assessment of the patients’ conditions. Many patients were terminally ill and receiving hospice care. The report describes products reimbursable by Medicare at more than $1,000 per square centimeter and alleges kickbacks from the wholesale distributor in exchange for ordering its products.

We see the absurdity in that account: the people earning money from the product were helping decide which patient needed it. The clinical assessment was supposed to answer the patient’s question. The alleged sales arrangement answered the distributor’s.

For a clinician or billing employee, the relevant connection runs through the referral, the wound assessment, the product applied and the claim. The person who knows why a graft was selected may explain a decision that the claim alone conceals.

2024 Takedown Subsequent Case Outcomes

The 2024 takedown’s subsequent case outcomes include a laboratory owner’s jury conviction, wound-care guilty pleas and separate civil agreements. Following those individual cases shows how the evidence developed after the national announcement.

The Laboratory Owner’s Trial

The Justice Department’s February 20, 2026 trial announcement reported that a jury convicted the owner of Axis and Kingdom the previous day of conspiracy, kickback and money-laundering offenses. The department’s account describes contracts, messages and invoices reverse-engineered to support explanations for payments.

That trial account reported approximately $328 million billed to Medicare and approximately $54 million paid. The original billing pattern led investigators toward the laboratories. The business records helped explain the arrangements behind the claims. For someone who handled a marketing contract or questioned an invoice, that is the part of the case to recognize.

Wound-Care Admissions and Civil Agreements

The annual report records guilty pleas by two nurse practitioners in August 2024 based on their application of medically unnecessary wound allografts. It also reports that an organizer pleaded guilty in October and admitted causing more than $1.2 billion in false claims to federal health care programs and secondary insurers, which paid more than $614 million.

A December 12, 2025 announcement of civil agreements separately reported that Apex Medical LLC and its operator agreed to pay $279,912,916. Another operator agreed to pay $30 million. The civil agreements resolved allegations concerning unnecessary allografts and referral kickbacks. Whistleblowers brought the civil cases. The underlying questions remain recognizable inside the business: who selected the patients, who chose the products, who was paid for the referrals and what the government was billed.

Why Enforcement Figures Need Their Own Context

The national action measures cases brought together for enforcement. Research into the amount of fraud asks a different question, including what might be happening in places investigators have not targeted.

Medicare Home Health Fraud: How Much, Where, and Who?, a National Bureau of Economic Research working paper issued in May 2026, studied Medicare home-health billing using claims and prosecution records. The researchers classified an agency as fraudulent if a federal strike force prosecuted it, then used a model to estimate which agencies elsewhere would have been prosecuted had a strike force been present.

They estimated that 3.4% of Medicare home-health spending in 2008 was billed by agencies classified as fraudulent under that method. The strike-force districts accounted for a disproportionate share of the spending the study classified as fraudulent:

The strike forces were well-targeted: their nine districts contained only 40% of home health spending but 65% of fraudulent spending.

Medicare Home Health Fraud: How Much, Where, and Who?, National Bureau of Economic Research, 2026

The paper also found that the agencies it classified as fraudulent more often relied on extremely high-volume referring physicians, showed unusually uniform patterns of care and served healthier patients. They illustrate why the referral pattern and the care described can be worth examining together.

That is the useful connection to the laboratory case: the billing pattern led to questions about who was ordering the care and how those orders were obtained. An insider’s account can explain the business decision behind the pattern.

What Someone Inside the Business Can Explain

Useful Medicare fraud evidence connects the order, the service, the claim and the payment with the decisions behind them. A practice employee may know how test requests arrived. A nurse may know whether anyone independently assessed a wound. An accounts-payable employee may know why a marketing invoice was rewritten.

Warnings have a history too: who raised a concern, who received it, what response came back and whether the same claims continued. We work with the person who can explain that history and connect it to the money. The national announcement is the public view. Your knowledge may explain what happened inside the business. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

When You Know How the Order Was Obtained

If you recognize the marketing payment, the pressured signature or the clinical decision that produced a false claim, talk with our whistleblower experts about what you saw. We shape your strongest Medicare whistleblower case around your knowledge and bring in Medicare fraud whistleblower lawyers who understand referral arrangements, clinical records and payment systems. We stay beside you through the case.

WHISTLEBLOWER JUSTICE NETWORK CAN HELP YOU
Make a difference.
Whistleblower Justice NetworkReport Fraud
100% CONFIDENTIALFREE CONSULTATION24 / 7 / 365